IDEXX Laboratories (UK) Insiders
0J8P Stock | 437.95 1.45 0.33% |
IDEXX Laboratories employs about 11 K people. The company is managed by 15 executives with a total tenure of roughly 25667 years, averaging almost 1711.0 years of service per executive, having 733.33 employees per reported executive. Breaking down IDEXX Laboratories' management performance can provide insight into the firm performance.
Jonathan Mazelsky CEO CEO President |
IDEXX |
IDEXX Laboratories Management Team Effectiveness
The company has return on total asset (ROA) of 0.2279 % which means that it generated a profit of $0.2279 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5942 %, meaning that it generated $0.5942 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IDEXX Laboratories' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 1.9 B in 2024, whereas Intangible Assets are likely to drop slightly above 66.7 M in 2024.Common Stock Shares Outstanding is likely to gain to about 94.9 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 563.5 M in 2024.
IDEXX Laboratories Workforce Comparison
IDEXX Laboratories is rated below average in number of employees category among its peers. The total workforce of Industrials industry is presently estimated at about 135,288. IDEXX Laboratories holds roughly 11,000 in number of employees claiming about 8% of equities under Industrials industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.37 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.37. IDEXX Laboratories Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. IDEXX Laboratories Price Series Summation is a cross summation of IDEXX Laboratories price series and its benchmark/peer.
IDEXX Laboratories Notable Stakeholders
An IDEXX Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IDEXX Laboratories often face trade-offs trying to please all of them. IDEXX Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IDEXX Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jonathan Mazelsky | CEO President | Profile | |
Brian McKeon | Executive CFO | Profile | |
Nimrata PE | Sector Strategy | Profile | |
Martin Smith | Executive CTO | Profile | |
Jeffery Chadbourne | Director Reporting | Profile | |
Sharon JD | General VP | Profile | |
Sharon Underberg | General VP | Profile | |
Michael Lane | Executive Technology | Profile | |
George Fennell | Senior Officer | Profile | |
Ken Grady | Senior Officer | Profile | |
Kerry Bennett | Senior Labs | Profile | |
Michael Johnson | Executive Officer | Profile | |
James Polewaczyk | Executive Officer | Profile | |
John Hart | Senior Operations | Profile | |
Michael Erickson | Executive Telemedicine | Profile |
About IDEXX Laboratories Management Performance
The success or failure of an entity such as IDEXX Laboratories often depends on how effective the management is. IDEXX Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IDEXX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IDEXX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
IDEXX Laboratories is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in IDEXX Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IDEXX Laboratories. Check IDEXX Laboratories' Beneish M Score to see the likelihood of IDEXX Laboratories' management manipulating its earnings.
IDEXX Laboratories Workforce Analysis
Traditionally, organizations such as IDEXX Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare IDEXX Laboratories within its industry.IDEXX Laboratories Manpower Efficiency
Return on IDEXX Laboratories Manpower
Revenue Per Employee | 332.8K | |
Revenue Per Executive | 244.1M | |
Net Income Per Employee | 76.8K | |
Net Income Per Executive | 56.3M |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.